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Many disease-associated variants identiﬁed by genome-wide association (GWA) studies are expected to
regulate gene expression. Allele-speciﬁc expression (ASE) quantiﬁes transcription from both haplotypes
using individuals heterozygous at tested SNPs. We performed deep human transcriptome-wide resequencing
(RNA-seq) for ASE analysis and expression quantitative trait locus discovery. We resequenced double
poly(A)-selected RNA from primary CD4
1 T cells (n 5 4 individuals, both activated and untreated conditions)
and developed tools for paired-end RNA-seq alignment and ASE analysis. We generated an average of
20 million uniquely mapping 45 base reads per sample. We obtained sufﬁcient read depth to test 1371
unique transcripts for ASE. Multiple biases inﬂate the false discovery rate which we estimate to be 50%
for random SNPs. However, after controlling for these biases and considering the subset of SNPs that
pass HapMap QC, 4.6% of heterozygous SNP-sample pairs show evidence of imbalance (P < 0.001). We
validated four ﬁndings by both bacterial cloning and Sanger sequencing assays. We also found convincing
evidence for allelic imbalance at multiple reporter exonic SNPs in CD6 for two samples heterozygous at the
multiple sclerosis-associated variant rs17824933, linking GWA ﬁndings with variation in gene expression.
Finally, we show in CD4
1 T cells from a further individual that high-throughput sequencing of genomic
DNA and RNA-seq following enrichment for targeted gene sequences by sequence capture methods offers
an unbiased means to increase the read depth for transcripts of interest, and therefore a method to investi-
gate the regulatory role of many disease-associated genetic variants.
INTRODUCTION
Genome-wide association (GWA) studies using single nucleo-
tide polymorphism (SNP) maps have revolutionized the
mapping of common genetic loci determining susceptibility
to a wide range of common, multifactorial disorders (1), in
particular autoimmune diseases (2). The next steps to follow
up on these ﬁndings are the identiﬁcation of particular
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molecular effects of these genetic variants. Because current
evidence suggests that only a small fraction of the causal
loci consists of variants (non-synonymous SNPs, copy-number
variants or indels) directly affecting the protein amino-acid
sequence, we expect a large fraction of the loci to have a regu-
latory role on gene expression via effects on transcription,
message stability and splicing. To investigate the potential
effects of candidate causal variants and haplotypes on gene
regulation researchers have been correlating SNPs with inher-
ited gene expression, known as expression quantitative trait
loci (eQTLs). The combination of genome-wide genotyping
with quantiﬁcation of mRNA transcripts using microarray
technology in sufﬁciently large cohorts has already demon-
strated the widespread presence of eQTLs in the human
genome (3–7). Most of these studies (3–5), however, used
lymphoblastoid cell lines immortalized using Epstein Barr
Virus and relied on observing differences between individuals
despite the large inter-individual variability of gene expression
measurements that is not explained by cis genetic variation, in
addition to the limited accuracy of hybridization-based gene
expression assays. This high variability generated by environ-
mental factors and additional non-measured genetic or epige-
netic variability signiﬁcantly reduces the statistical power for
eQTL discovery. Therefore, measurement of expression
levels across multiple individuals may be so noisy that reliable
correlations between SNP alleles and gene expression levels
cannot always be demonstrated when the difference of
expression between haplotypes is small (less than 1.3 fold).
Moreover, cell lines may not be representative of in vivo
biology and may introduce even greater variability (8–10),
and, therefore, gene expression analyses using puriﬁed
primary cell populations are urgently required (6–7,11).
An alternative experimental design well suited to address
these limitations is allele-speciﬁc expression (ASE) analysis.
This approach quantiﬁes (un)equal transcription (or splicing)
from the two alleles or haplotypes using RNA samples
from individuals who are heterozygous at the eQTL SNP of
interest. The elegant ASE approach has the major advantage
of assessing expression within an individual rather than
across subjects thereby avoiding major sources of error and
variation.
In parallel, recent advances in high-throughput resequencing
technologies have enabled highly quantitative sequencing-based
analysis of human transcriptomes [RNA-seq (10,12,13)].
Because these techniques separately resequence both haplo-
types, they have the potential to be used for the quantiﬁcation
of allelic imbalance, provided that a heterozygous SNP which
can be used as a marker for each haplotype exists in the tran-
script of interest. The potential of this method for ASE analy-
sis has been demonstrated in pooled cDNA samples and
human cell lines (14). Here, we extend this approach to
eight independently sequenced human poly(A)-selected tran-
scriptomes obtained from primary cells from healthy donors
using high-throughput paired-end (PE) resequencing. In the
context of the recently identiﬁed shared pathways between
multiple autoimmune disorders (2,15) that motivated this
study, many of the most relevant genes in regions identiﬁed
by GWA studies are immune genes that are highly expressed
in CD4
þ T cells. This observation suggested the use of
primary CD4
þ T cells in the current ASE study, thus illustrating
the potential of this approach to identify regulatory effects in
puriﬁed primary cell subsets.
RESULTS
Data description
We used Illumina Genome Analyzer II (GAII) high-
throughput resequencing of cDNA libraries obtained from
poly(A)-puriﬁed mRNA from four individuals analysed
under T-cell activation (stimulated) or unstimulated conditions
(see Materials and Methods), resulting in a total of eight
samples. We obtained 45 bp reads, the majority of them are
paired end (i.e. containing reads from both the 30 and 50 end
of a 250 bp fragment, see Table 1), that were mapped to a
transcriptome reference sequence set speciﬁcally constructed
for PE RNA-seq (see Materials and Methods). This reference
set includes a spliced transcript for each annotated gene
(Ensembl CCDS), as well as additional sequences for introns
and non-standard splice junctions. A full version of the refer-
ence gDNA genome with annotated gene regions masked was
added to enable: capture of transcribed, but not annotated,
chromosome regions; detect gDNA contamination of the
mRNA preparation and importantly to allow assessment of
repetitive sequence. Only reads mapping with high conﬁdence
to a unique location in our reference sequence set (deﬁned as
quality reads, see Materials and Methods) were included in
this study.
Owing to the complex nature of the RNA-seq reference
genome, taking advantage of PE sequence reads relies on
the ability of the mapping algorithm to map ‘chimeric’ frag-
ments: for example, the ﬁrst read of a pair may map to a non-
standard exon–exon junction sequence and the second read to
the main spliced transcript. An algorithm implementing this
feature was provided by the novoalign (www.novocraft.com)
software package, which we used to align resequencing
reads to our reference set. Another useful feature provided
by novoalign is the ability to set a lower penalty for alignment
when a ‘chimeric’ paired read maps to two sequences that are
part of the same gene.
Transcript coverage
In the absence of experimental biases, the ability to detect an
allelic imbalance using ASE depends on two parameters:
the strength of the allelic imbalance and the read depth at
the reporter heterozygous SNP. We analytically computed
the read depth required to demonstrate allelic imbalance for
different allelic ratios. Power calculations (Fig. 1) show that
for a read depth of 50 and a 67:33 allelic imbalance, which
corresponds to an average of one cycle difference in a qPCR
experiment between individuals homozygous at both alleles
(a two fold difference), the probability to observe a P-value
more signiﬁcant than 0.001 is 19% (Fig. 1). Therefore, to
remove SNPs providing almost no power to detect allelic
imbalance, we only tested for ASE SNPs with read depth  50.
While this approach is not limited to previously known
SNPs, we ﬁrst tested 589 673 dbSNPs for ASE (obtained
from Ensembl release 52) and located in annotated spliced
Human Molecular Genetics, 2010, Vol. 19, No. 1 123transcripts (including 50/30 untranslated regions) in order to
limit biases associated with simultaneous SNP discovery and
ASE testing. We also tested for ASE 4 282 208 intronic
dbSNPs but owing to the use of poly(A)-selected mRNA the
vast majority of the SNPs with sufﬁcient read depth were
located in spliced transcripts (96.4%). Heterozygous SNPs
with sufﬁcient read depth were located in highly expressed
transcripts and we obtained sufﬁcient read depth to test 4929
pairs of heterozygous SNPs/samples for allelic imbalance.
Grouping these SNPs by transcripts for each of the eight
samples provided 3107 pairs transcripts/samples with sufﬁ-
cient coverage for ASE analysis. When counting each SNP
uniquely, we had sufﬁcient data to test 1371 transcripts and
2701 SNPs for ASE. In each individual, the number of testable
transcripts (i.e. containing at least one heterozygous SNP with
sufﬁcient read depth) was proportional to the number of
mapped reads (Fig. 2,R
2 ¼ 0.91).
Overall distribution of allelic imbalance
When considering the overall distribution of the test statistic,
we found evidence of widespread departure from 1:1 allelic
ratio. Summing over the eight samples, we tested a total of
4929 pairs of heterozygous SNPs/samples with sufﬁcient
read depth (.50), and 370 SNPs (7.5%) showed evidence of
allelic imbalance at P , 0.001 (Table 1). At this signiﬁcance
level, the estimated theoretical false discovery rate (FDR) is
1%. However, we have identiﬁed several biases inﬂating
the false positive rate (see below for a description). Since
SNPs passing HapMap quality ﬁlters are less likely to be
affected by some of these biases (for example, indels close
to an SNP will inﬂuence primer/probe hybridization), the
ASE rate for HapMap SNPs is a more reliable estimate of
the true rate of ASE. Indeed, when we restricted the analysis
to the subset of 87 796 dbSNPs in spliced transcripts that
passed HapMap quality ﬁlters, the ASE rate was signiﬁcantly
lower: 4.6% of heterozygous HapMap SNPs/sample pairs
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Figure 1. Probability to detect an allelic imbalance at P , 0.001 as a function
of the read depth at a single SNP. We considered three levels of allelic imbal-
ance: 60/40, 67/33 and 70/30. The 67/33 scenario corresponds to a two-fold
difference in expression level, i.e. an average of one cycle difference
between individuals homozygous at both alleles in a qPCR experiment.
124 Human Molecular Genetics, 2010, Vol. 19, No. 1were ASE positive (115 out of 2478 heterozygous HapMap
SNPs with sufﬁcient read depth, P ¼ 2.47   10
214).
However, our statistical power to detect allelic imbalance is
limited by read depth and, therefore, this estimate of 4.6% is
a lower bound. Indeed, when restricting this analysis to
HapMap SNPs with read depth .100, we found a higher
ASE rate of 7.5% (66 of 878). A complete list of all the het-
erozygous dbSNPs with sufﬁcient read depth for ASE
testing is provided in Supplementary material, Table S1.
Genotyping data and epigenetic effects
Our approach consisting of identifying heterozygous SNPs
using solely the RNA-seq data restricts our ASE analysis to
SNPs for which the observed imbalance level does not
exceed 15–85%, the threshold beyond which SNPs are
called homozygous. With the double purpose of conﬁrming
RNA-seq calls and identifying heterozygous SNPs completely
imbalanced in the RNA-seq data, we therefore genotyped the
four individuals using the Illumina Quad660W BeadChip. We
lowered to 20 the minimum read depth required to call SNPs
in the RNA-seq data and identiﬁed 9727 pairs of SNP/samples
shared between RNA-seq and Illumina Quad660W genotyping
chip. Out of these 9727 calls, 6886 are homozygous based on
the genotyping chip data. Out of these 6886 calls, only one call
is inconsistently called heterozygous in RNA-seq (rs7484182
in individual 2) and visual inspection of the genotyping chip
clustering plots showed poor quality data consistent with a
genotyping error.
Conversely, out of the 2841 genotyping chip heterozygous
calls, 14 are homozygous based on the RNA-seq data. Four
of these 14 inconsistent calls were located in the transcript
SNRPN, a known parentally imprinted gene, thus explaining
its monoallelic expression. Three calls were located in
ERAP2, a gene with known complete cis-acting differential
allelic control [but not parentally imprinted, see (16)]. After
removing these, 7 of 2841 calls (0.24%) located in seven
different transcripts remain inconsistent. For four of these
calls (located in IQGAP1, TMBIM4, CALHM2, AL031281.6),
the read depth was ,30 and we observed low levels of
expression of the alternate allele. This is consistent with
either highly skewed allelic expression or simply the result
of random sampling of both alleles at low read depth. The
remaining three calls (located in CD44, VAMP1 and
NAPRT1) may be real, or alternatively the result of unex-
plained artefacts either in the RNA-seq or the genotyping data.
Single locus validation
In order to conﬁrm that some of our ﬁndings are not the con-
sequence of technical biases, we selected four pairs of
HapMap SNPs/individuals and validated them using two
different locus-speciﬁc assays [clone-based allele-speciﬁc
expression (C-BASE) (17) and PeakPicker (18)]. The
C-BASE ASE assay relies on ampliﬁcation by PCR of
cDNA or genomic DNA fragment containing the reporter het-
erozygous SNP, followed by ligation into a vector and trans-
formation into bacterial competent cells. Bacterial colonies
are genotyped and both SNP alleles are counted, generating
allelic counts reﬂecting the relative proportion of the two
alleles in vivo. The PeakPicker ASE method uses sequencing
trace data to quantify the relative ﬂuorescent intensity for
both alleles at heterozygous SNPs. The sequencing trace ﬂuor-
escent intensities are summarized by the ratio of peak heights
for both alleles.
We selected four combinations of HapMap SNPs/samples
showing convincing evidence of ASE in the transcriptome
resequencing data for replication using the locus-speciﬁc
approach. All four initial RNA-seq results replicated and
PeakPicker/C-BASE provided consistent results (Table 2 and
Supplementary material, Table S2 for details of replication
assay). Note that because we have observed for C-BASE
assay allelic bias even using genomic DNA level as the PCR
template (see, for example, rs1060819 in Table 2), the C-
BASE ASE test uses a 1df goodness-of-ﬁt x
2 test for equal
cDNA/gDNA allelic ratio, thus using the gDNA allelic distri-
bution as control. Using gDNA allelic ratio as an internal
control for mRNA imbalance is a more robust design, but
obtaining this gDNA control for high-throughput sequencing
data is, currently, prohibitively expensive owing to the very
large amount of high-throughput resequencing needed to
obtain high read depth for gDNA using whole genomes.
This limitation points to future modiﬁcations of the approach
by using sequence capture in order to enrich the cDNA for
target sequences and to increase read depth for genomic
DNA and RNA-seq (see below).
ASE analysis of disease-associated genes
The subset of primary cells used in this study (CD4
þ T cells)
was chosen for its relevance to autoimmunity. Therefore, we
reviewed the literature and identiﬁed 79 genes previously
associated with autoimmune disorders (2,19). To maximize
the number of testable heterozygous SNPs, we included in
this analysis new heterozygous SNPs not listed in the Ensembl
database but discovered by analysing our transcriptome
Figure 2. Number of transcripts containing at least one heterozygous dbSNP
with read depth 50 (black), 100 (red) and 250 (green) as a function of the
number of quality 45 bp reads. Each point represents one condition/individual
sample. To provide a more intuitive reference, a mean 1  read-depth across
the human genomic DNA requires 65 million 45 bp reads.
Human Molecular Genetics, 2010, Vol. 19, No. 1 125resequencing data. In these 79 genes (Supplementary material,
Table S3), we found 61 heterozygous SNPs with read depth
.50 and eight of them were not listed in dbSNP (13.1%).
These 61 heterozygous SNPs were found in 22 genes, i.e.
28% of the targeted genes, an elevated rate consistent with
a higher expression level of these immune genes in CD4
þ
T cells. Counting separately each pair of SNP/individual,
we tested a total of 127 pairs and 13 were imbalanced at P ,
0.001. After controlling for the elevated read depth, the fre-
quency of ASE positive pairs of SNP/sample in these 79 tran-
scripts was consistent with genome-wide estimates (P . 0.05).
Firstly, 8 of 13 imbalanced SNPs were located in the mul-
tiple sclerosis-associated gene CD6 (20). In individual 2
(stimulated and unstimulated), two heterozygous exonic
SNPs (HapMap SNP rs2074225 and rs11230562, separated
by 97 bp in the spliced transcript) showed strong level of
imbalance (allelic counts 253/142 at rs11230562 and 237/
170 at rs2074225). Both SNPs were sufﬁciently close to
obtain phase information from the RNA-seq 45 bp PE reads
(using novoPhase, see Materials and Methods) and these
data conﬁrmed that the same haplotype was over-represented
at both SNPs. Note that a third SNP (rs1050922) in individual
2 had 1:1 allelic ratio but also unexpectedly high read depth
(two fold increase over rs2074225/rs11230562). This could
be the consequence of reads from another transcript mapping
to a homologous region in the CD6 transcript and we
believe that the data at this SNP are artefactual. We also
found three CD6 heterozygous SNPs in individual 3 and
these SNPs were sufﬁciently close to be phased using the
RNA-seq paired reads. For all three SNPs, the pattern was
consistent after phasing, the same haplotype being over-
represented at all three SNPs (counts 176/155 at rs61899223,
95/56 at rs11230562 and 83/64 at ENSSNP10443844, where
the ﬁrst number relates to the same haplotype). For individual
4, we found four heterozygous SNPs (including two adjacent
SNPs) but after phasing the data were inconsistent: different
haplotypes were over-represented at different SNPs,
suggesting the possibility of unidentiﬁed biases
[e.g. alternative splicing at CD6 (21)]. Given the convincing
evidence of association for individuals 2 and 3, we genotyped
all individuals for the SNP currently strongly associated with
multiple sclerosis in CD6, rs17824933 (20). Both individuals
2 and 3 (but not individuals 1 and 4) were heterozygous at
this SNP. Taken together, these data suggest that the alteration
of CD6 expression in CD4
þ T cells is a potential mechanism
for the effect of the multiple sclerosis-associated variant in the
CD6 gene region. SNP phasing obtained from linkage disequi-
librium information at HapMap SNPs rs2074225 and
rs17824933 shows that the minor allele G of rs17824933,
which is more common in multiple sclerosis patients than con-
trols, is associated with lower CD6 expression. However, the
biological interpretation is complex as resting CD6 expression
inhibits T-cell activation, but CD166 ligand engagement of
CD6 enhances T-cell activation (22).
Secondly, we observed an intriguing pattern at ICOSLG,i n
which ﬁve heterozygous SNPs, all not listed in dbSNPs, were
identiﬁed in individual 2 and a strong skew was observed for
four of them. Moreover, after phasing the data, we identiﬁed
three distinct haplotypes instead of two, suggesting that the
observed skew is artefactual. We scanned the database of
genomic variants and found that, according to two independent
studies(23,24),theentiregeneislocatedinacopynumbervari-
able region. Our data suggest that this copy number variation is
a duplication and that the duplicated gene is expressed: the
additional observed haplotype in individual 2 probably orig-
inates from this duplicated copy. This additional copy is prob-
ably expressed at a lower level than the original transcript
which would explain the imbalance in the RNA-seq data.
Lastly, we identiﬁed six heterozygous SNPs in the IL21R
gene (25) for individual 1, two of them imbalanced at P ,
0.001. We could phase three of six heterozygous SNPs
(rs2285452, rs3093387 and rs2239928) using the RNA-seq
data, and the trend was consistent with 1.3:1 allelic ratio.
This ﬁnding is consistent with a previous report of a IL21R
eQTL using mRNA from the peripheral blood of 110 celiac
cases (7).
Table 2. Comparison of allelic imbalance between mRNA transcriptome resequencing (RNA-seq) and two validation assays: locus-speciﬁc bacterial cloning
(C-BASE) and PeakPicker. Both validation assays tested total RNA and genomic DNA. Allele 1 indicates the allele in the reference genome. RNA-seq P-values
use a x
2 goodness-of-ﬁt test for a 50–50 allelic ratio. For the C-BASE validation assay P-values test for equal allelic ratio in mRNA and gDNA using a 1df x
2
goodness-of-ﬁt test.
Sample Gene SNP mRNAresequencing (RNA-seq) Validation: C-BASE Validation:
PeakPicker
mRNA Counts Total RNA
Counts
gDNA counts Ratio of
normalized peak
heights, allele 1
by allele 2
Allele
1
Allele
2
P Allele
1
Allele
2
Allele
1
Allele
2
P (gDNA by
total RNA)
Total
RNA
gDNA
Individual 1,
stimulated
FAM118A rs2064068
(G/A)
82 23 8.5   10
29 229 101 186 150 2.5   10
24 1.91 0.95
Individual 4,
stimulated
FAM118A rs2064068
(G/A)
73 25 1.2   10
26 211 95 168 166 2.4   10
26 1.76 0.97
Individual 4,
stimulated
CALM3 rs10405893
(A/G)
149 86 4   10
25 202 117 176 167 2   10
23 1.54 1.08
Individual 4,
stimulated
ATHL1 rs1060819
(T/C)
82 223 6.8   10
216 95 232 196 145 1.3   10
213 0.43 0.86
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The Illumina GAII sequencing chemistry induces biases that
can increase the rate of false positive ASE. A ﬁrst issue is
PCR biases over-amplifying identical cDNA fragments, the
ﬁnal allelic ratio being eventually affected by the presence
of a large number of over-represented identical read clones.
To control for these biases, we identiﬁed clonal molecules in
the PE data using as a signature the mapping location for
both reads in a pair (or if one read did not map uniquely,
the ﬁrst 10 bp of sequence was used as a signature). Identical
mapping location for both 45 bp reads is unlikely to occur ran-
domly, and for each set of clonal read pairs we only included a
single read pair in the analysis. This ﬁltering process removed
on average 10% of the reads from the ﬁnal analysis (option
rmDup in novoPile). To ensure our ASE results are not
affected by clonality, especially for reads mapping as single
end (SE) data for which the ﬁlter described above is not appli-
cable, we also veriﬁed that among the reads covering a hetero-
zygous SNP the observed allele was independent of the
position of the SNP within each 45 bp read (see Materials
and Methods).
Secondly, we also observed biases that are speciﬁc to
forward/reverse read direction. Therefore, we veriﬁed that
for heterozygous SNPs the allelic ratio distribution was con-
sistent for read counts obtained for the reverse and forward
strands. Using a P ¼ 0.01 threshold for both tests, we
removed 18% of heterozygous dbSNPs from ASE testing.
Controlling for in silico mapping biases
In silico artefacts in the mapping procedure can also bias the
allelic ratio distribution and increase the false positive rate.
A general difﬁculty is the mapping of short reads to a standard
reference sequence that does not match perfectly the genetic
sequence of the sample. In particular, for heterozygous
SNPs, the allele concordant with the reference is more likely
to be mapped, resulting in a bias towards the reference allele
and an inﬂated rate of false positive ASE.
In silico mapping procedures relying on a conservative
threshold (no more than two mismatches) are heavily affected
by this bias (Fig. 3). We solved these issues by incorporating
two additions to our mapping algorithm. Firstly, for all known
dbSNPs, we replaced the reference allele with the correspond-
ing genetic ambiguity code coding both possible alleles at this
SNP. Secondly, we relaxed the threshold on the number of
mismatches for allowing reads to be mapped in order to
limit the impact of a small number of mismatched SNPs.
Our mapping procedure uses a probability-based alignment
score that typically allows up to ﬁve mismatches (option
-t150 in novoalign), and reads with more than ﬁve mismatches
were discarded at later stages (see Materials and Methods).
These two additions corrected most of the reference allele
bias (Fig. 3).
Additional differences, such as other heterozygous SNPs
or indels, further contribute to differential mapping of both
haplotypes. The novoalign algorithm provides calls for small
indels (up to 13 bp). Using these calls, we found an increased
proportion of imbalanced SNPs within 45 bp of indels. Before
applying any quality control ﬁlter (see above), 42% of
heterozygous SNPs within 45 bp of a called indel were imbal-
anced at P , 0.001 (233 out of 545 calls). This proportion was
11.7% when no indel was called within 45 bp (737 out of 6311
calls). After applying the quality ﬁlters, these proportions
became 24% for SNPs within 45 bases of an indel, and
7.5% otherwise. In both cases the difference is highly signiﬁ-
cant (P ,,10
210). These results suggest that the quality
ﬁlters capture only a fraction of the artefacts caused by
indels. Consequently, we excluded from our ASE analysis het-
erozygous SNPs within 45 bp of a called indel in the same
individual.
Additional sources of false positive ASE
However, it is likely that even after applying these quality
ﬁlters copy number variation and mapping biases still
account for a number of false positive ASE results. In particu-
lar, intermediate size indels larger than 13 bp cannot be
called by novoalign with the settings we used for read
mapping. We used the software Pindel (26) to re-analyse the
RNA-seq data with the purpose of identifying new larger
indels (this tool can detect 1–10 kb indels). However, we
could ﬁnd new indels within 300 bp of the heterozygous
SNP for only 11 positive ASE results.
In addition, low-complexity or repeat sequence surrounding
heterozygous SNPs is associated with an elevated ASE posi-
tive rate. We used as criteria for low-complexity/repeat
sequences the fact that more than 25% of the 90 bp surround-
ing sequence (45 bp on each side) was masked by RepeatMas-
ker. We found that roughly 12% of the heterozygous SNPs in
this study were located in low-complexity regions. For SNPs
in such low-complexity regions, the ASE positive rate was
23%. Overall, 28% of ASE positive SNPs are located in low-
complexity DNA regions. The ASE rate was also elevated for
intronic SNPs (33/208¼15.8% ASE positive SNPs), which are
more likely to contain small indels.
Lastly, the ASE positive rate was lower for heterozygous
SNPs that passed HapMap quality ﬁlters: 115 ASE positive
SNPs out of 2478 ¼ 4.6%, compared with 7.5% for the non-
ﬁltered set (370/4929 heterozygous SNPs). This difference
between HapMap SNPs and non-HapMap SNPs is signiﬁcant
(P ¼ 2.47   10
214) and consistent with the fact that SNPs
passing HapMap quality ﬁlters are not likely to be located in
repeat sequences or near indels. A similar reduction of ASE
positive rate was observed for SNPs on the Illumina
Quad660W genotyping chip (32/797 ¼ 4.01%).
To obtain a more accurate assessment of potential biases,
we attempted to validate additional ASE results. We used indi-
vidual 1 data and selected 22 transcripts with a unique imbal-
anced heterozygous SNP in each transcript (Supplementary
material, Table S4). We ﬁrst resequenced the gDNA to ident-
ify potential indels and obtained usable sequence data for 19
of 22 SNPs. We found only one previously undetected 1 bp
indel within 45 bp of the heterozygous SNP, providing a
likely explanation for the observed imbalance at this SNP.
However, resequencing data showed that 5 of 19 SNPs are
in fact homozygous. None of these ﬁve SNPs passed
HapMap QC, and this discrepancy is most likely the conse-
quence of RNA-seq mapping errors with homologous DNA
regions.
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primers to resequence both gDNA and total RNA (Supplemen-
tary material, Table S4). Sequence data were usable for 9 of 13
SNPs for which we used the PeakPicker method (18) to quan-
tify potential imbalance. Three of nine SNPs convincingly
validated (cDNA by gDNA allelic ratio .1.5). For two out
of six remaining SNPs, the estimated imbalance from
RNA-seq was low (no more than 60:40) and for these SNPs
the limited sensitivity of the PeakPicker validation assay
when the allelic imbalance is ,1.5-fold can potentially
explain the lack of validation. For the remaining four SNPs,
the PeakPicker validation data showed no evidence of allelic
imbalance in spite of a strong bias observed in the RNA-seq
data and we found no obvious explanation to account for
this discrepancy. In addition to limited sensitivity, the
interpretation is also complicated by the fact that our vali-
dation data used total RNA but the RNA-seq ﬁndings used
poly(A)-selected RNA. We did not apply the more sensitive
counting ASE method C-BASE owing to time constraints
and the laborious nature of this assay.
Taken together, these data suggest that several biases, some
of them unknown, increase the FDR. Even if one assumes that
the ASE FDR is relatively small for HapMap SNPs, the differ-
ence in ASE positive rate with non-HapMap SNPs suggests
that the false positive rate among non-HapMap SNPs is
50%. However, this rate could potentially be higher,
especially for heterozygous SNPs surrounded by repeat
sequences or small indels. Thus ‘unproven quality’ SNPs
Figure 3. Effect of mapping parameters (number of mismatches allowed for read mapping, and/or masking dbSNPs from the reference sequence set) on the
allelic ratio distribution using the PE data for individual 2 stimulated at heterozygous dbSNPs passing quality checks and with read depth .50. Red crosses
indicate signiﬁcant allelic imbalance (P , 0.001). The bottom-right histogram has been generated allowing up to ﬁve mismatches and mapping reads to the
masked reference set. Nb, number.
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the presence of multiple imbalanced SNPs is required to
provide convincing evidence of ASE. In addition, the corre-
sponding ASE for gDNA is a desirable control.
PE versus SE reads
To compare PE and SE mapping, we used the PE data for indi-
vidual 2 stimulated (as shown in Fig. 3) which we mapped
either as PE or SE reads. Using the frequency of the reference
allele as a diagnostic for in silico mapping issues, the distri-
butions obtained using PE and SE mapping were indistin-
guishable (data not shown). However, using the same quality
threshold, the PE approach mapped 19% more quality reads
than the SE approach. This difference indicates that the PE
approach is more cost-effective than the SE approach for
this ASE design, in addition to other advantages for
RNA-seq experiments including splice junction mapping and
de novo assembly.
Sequence capture
The main limitation of the full poly(A)-selected transcriptome
resequencing is the limited read depth at genes that are insuf-
ﬁciently expressed. To address these issues, we investigated
the potential of the cDNA enrichment with sequences of inter-
est using recently developed sequence capture methods (27).
As a pilot study, we designed a sequence capture Nimblegen
hybridization array targeting 25 genes located in immune
disorders-associated chromosome regions. We also included,
as a positive control, the FAM118A transcript, a gene ident-
iﬁed in this study and another (4) as an eQTL transcript. In
total we targeted 26 genes and a total sequence length of
1.7 Mb.
Based on available FAM118A eQTL data (4) we used the
Cambridge BioResource [www.cambridgebioresource.org.uk
(28)] to recruit for a blood donation individual 5, selected to
be heterozygous at the FAM118A eQTL. The Cambridge
BioResource is a collection of over 5000 healthy volunteers
in the Cambridge area that can be recalled by genotypes.
Using the Nimblegen capture array, we captured genomic
DNA and cDNA obtained from poly(A)-selected RNA for
this individual. We then resequenced both samples using Illu-
mina GAII sequencer and 76 bp PE reads (9.35 M pairs of
reads for gDNA and 20 M pairs of reads for RNA).
Sequence capture successfully enriched both resulting pro-
ducts with target sequences. In the poly(A)-selected data,
61.58% of the total number of reads and 87.46% of the
uniquely mapping reads mapped within 76 bp of the 1.7 Mb
target sequence. For the gDNA data, these numbers were
76.61% of the total number of reads and 67.27% of the
number of uniquely mapping reads. In contrast, in the
absence of sequence capture for individuals 1–4, we found
that 0.2–0.4% of the full poly(A)-selected transcriptome
reads mapped to the 1.7 Mb regions targeted by the capture
array, indicating that capture enriched for sequences of interest
by an average 200-fold.
However, following sequence capture, we discarded 86.7%
of the RNA reads and 52.96% of the genomic DNA reads
because of PCR clonality issues. Such clonal reads were
identiﬁed on the basis of having identical mapping locations
for both reads in a pair. These biases most likely result from
our use of PCR ampliﬁcation both before and after hybridiz-
ation on the capture array and are particularly problematic
when dealing with limited levels of input DNA/cDNA,
either prior to array capture or following array capture at the
sequencing step. We are currently considering alternative
library preparations and sequence capture protocols to circum-
vent these issues.
Nevertheless, after excluding duplicate clonal reads, we
obtained sufﬁcient data to perform ASE analysis for gDNA
and RNA at the positive control gene FAM118A (Fig. 4).
After applying the quality control procedures described in
this study, we found 43 heterozygous SNPs with read depth
.50 in the gDNA data. Only one SNP was not in dbSNP
and 21 of 43 passed HapMap quality ﬁlters. In the RNA
data, we found 21 heterozygous SNPs with read depth .50.
Seven of 21 passed HapMap quality ﬁlters and 1 of 21 was
not in dbSNP. Of the 21 heterozygous RNA SNPs, 14 also
had sufﬁcient read depth in the gDNA and as expected the
gDNA data were consistent with a 1:1 allelic ratio
(P.0.001 at all 43 SNPs). The consistency with 1:1 allelic
ratio observed in the gDNA data indicates that no allelic
bias was introduced by the sequence capture, a critical require-
ment for this experimental design.
In contrast, 10 of 21 heterozygous SNPs were signiﬁcantly
imbalanced in the RNA data at this P , 0.001 threshold (and
14/21 at P , 0.01). Analysis of the RNA data also showed that
77.5% of the heterozygous SNPs with read depth .50 are
intronic SNPs, indicating that the sequence capture approach
retains sufﬁcient read depth even in introns when capturing
cDNA from poly(A)-selected RNA.
DISCUSSION
Using a full poly(A)-selected transcriptome resequencing
approach (RNA-seq) applied to eight CD4
þ T-cell samples
obtained in untreated and activated conditions from four
healthy individuals, we performed a transcriptome-wide scan
for ASE. We identiﬁed several biases that inﬂate the ASE
false positive rate and to control for these biases while maxi-
mizing the information obtained from the data, we developed a
novel approach for mapping PE sequence reads to the human
transcriptome. For pairs of HapMap SNPs/samples, the pro-
portion of ASE positive results was 4.6%, a rate signiﬁcantly
lower than what we observed for the full set of heterozygous
SNPs (7.5%). This comparison shows that for randomly
selected ASE positive heterozygous SNPs of ‘unknown
quality’, the FDR is probably as high as 50%. However, the
fact that, using two independent locus-speciﬁc assays, all
four attempted ASE validations at HapMap SNPs were suc-
cessful suggests that this FDR is limited for SNPs that
passed HapMap quality ﬁlters. In situations where there is
uncertainty regarding genetic variation in the sequences sur-
rounding the assayed SNPs, the presence of several imbal-
anced SNPs in the same transcript is necessary to provide
reassurance that an ASE ﬁnding is indeed a true positive.
Nevertheless, only independent validation can unequivocally
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odology presented here.
Our data show that the effect of indels on the mapping of
short sequencing reads is a major source of false positive for
ASE. Longer sequencing reads, improved analytical methods
and use of PE reads will facilitate indel calling in the future
and longer reads will also improve the reliability of mapping
procedures. However, other biases, some yet to be discovered,
also contribute to the false positive rate. In particular,
a previous study (28) has shown that the RNA fragmentation
and the subsequent gel puriﬁcation step for the sequencing
library preparation can also introduce biases differentially
affecting both haplotypes. Such biases will not necessarily be
solved by the improvement of DNA sequencing technologies.
An advantage of our full transcriptome resequencing
approach is the ability to interrogate the entire genome for
ASE while avoiding the biases associated with the ampliﬁca-
tion of speciﬁc mRNA/cDNA sequences. The drawback is
Figure 4. ASE data for individual 5 following sequence capture for genomic DNA (top) and RNA (bottom) at the FAM118A positive control known eQTL
transcript. Crosses mark the read depth at each heterozygous SNP (only heterozygous SNPs with read depth .50 are shown). Vertical bars show the 99.9%
conﬁdence interval for the imbalance computed as the ratio between the most common and the least common of the two alleles for each heterozygous
SNPs. Red bars mark heterozygous SNPs showing signiﬁcant imbalance (at P , 0.001). The horizontal bar marks the 1:1 allelic ratio.
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expressed transcripts also including a heterozygous SNP in
the transcript-encoding sequence. Indeed, read depth is the
key determinant of statistical power for this ASE approach
and the analysis of rested and activated samples in this study
was initially motivated by the need to increase the expression
level of speciﬁc transcripts. For example IL2, a T1D
disease-associated gene (www.t1dbase.org), requires acti-
vation to be expressed at a sufﬁcient level for ASE analysis.
To capture more subtle levels of allelic imbalance, an even
greater read depth (as high as 1000) would be beneﬁcial, if
practical, both for a genome-wide screen or locus-speciﬁc
validation assay. The rapidly increasing throughput of DNA/
cDNA resequencing technologies will most likely soon
provide that level of read depth for a large number of tran-
scripts, either in poly(A)-selected or even total RNA.
Our preliminary data show that the enrichment of cDNA with
sequences of interest using sequence capture methods (27) fol-
lowed by high-throughput sequencing is an effective way to
increase the read depth at transcripts of interest. Alternatively,
another study (29) has proposed padlock-capture of targeted
sequences containing known SNPs to increase read depth. In
addition to the increased read depth, the sensitivity to detect
introns in preRNA (probably from partially unspliced hetero-
nuclear RNA with a poly(A) tail) provides increased poly-
morphism levels compared with exonic sequences, and
therefore more heterozygous SNPs for ASE testing. Joint
sequencing of genomic DNA, also enriched for the regions of
interest, enables screening of the heterozygous SNPs for 1:1
ratio in genomic DNA, thus facilitating detection of small
indels and repeat sequences that increase the ASE false positive
rate. Our preliminary study using Nimblegen sequence capture
arrays for T-cell total RNA detect retained introns at high read
depth in several genes from target regions. Furthermore, if a
particular transcript is of interest, speciﬁc samples can be
selected from a collection of individual volunteers of known
genotype (e.g. www.cambridgebioresource.org.uk) to ensure
the presence of heterozygous SNPs.
A successful combination of sequence capture and deep
sequencing of cDNA generated from total or poly(A)-puriﬁed
RNA with sufﬁcient coverage has the potential to simul-
taneously test for ASE, in speciﬁc primary cell subsets, most
ﬁndings identiﬁed by GWA scans, provided that the
expression levels of the transcripts are sufﬁcient and heterozy-
gous SNPs are available. This experiment would be useful not
only to demonstrate a potential regulatory effect of these
disease-associated alleles, but also to ﬁne-map-associated
regions by testing for ASE in carefully selected rare recombi-
nant individuals. Last, repeating the experiment for different
cell subsets will enable the identiﬁcation of the cell popu-
lations in which this regulatory role exists (28), thus helping
researchers link GWA ﬁndings with the molecular function
of these susceptibility alleles.
MATERIALS AND METHODS
Sample description
Primary CD4
þ human cells were extracted with Rosettesep
(Stem Cell Technologies, UK) negative selection from leuco-
ﬁlters obtained from the National Blood Service (individuals
2, 3 and 4). Cells from individuals 1 and 5, obtained from
venous blood through the Cambridge BioResource (28),
were puriﬁed from ﬁcoll-isolated PBMC using Dynabeads
untouched human CD4
þ T cells negative selection kit (Invitro-
gen Corp., UK). Purity was assessed by ﬂow cytometry
(.95% for all samples) while viability was assessed by
Trypan blue staining (.93% for all samples). CD4
þ T cells
were cultured for 3 h in X-Vivo media with 1% human AB
serum alone (Lonza, UK) or stimulated for 3 h at 378C, 5%
CO2 in plates pre-coated with 1 mg anti-CD3 (clone: OKT3,
eBioscience, USA) with the addition of 2 mg anti-CD28
(eBioscience).
Illumina library construction
RNA was extracted using the RNeasy kit (QIAGEN, UK) fol-
lowing the manufacturer’s instruction. Samples were subjected
to additional DNase treatment using Turbo-DNase (Ambion,
UK). RNA quantiﬁcation and quality were assessed using
Nanodrop (Nanodrop Technologies, USA) and RNA 6000
Agilent Bioanalyzer chip (Agilent Technologies, USA). A
double poly(A) RNA isolation was performed on 10 mgo f
total RNA (Invitrogen). Poly(A) RNA was fragmented for
exactly 5 min at 708C in fragmentation buffer (Ambion)
prior to random hexamer reverse transcription and second
strand synthesis as previously described (10). Illumina GAII
PE adapters were ligated to the DNA and the library generated
according to the standard library generation protocol (Illu-
mina, USA). A 300 bp size range was excised from the
library on 2% agarose gel. The resultant library was subjected
to 15 cycles of PCR (Phusion  DNA polymerase, Finnzymes,
Finland). The library was quantiﬁed by Nanodrop (Nanodrop
Technologies) and assayed for size using a DNA 7500
Agilent Bioanalyzer chip (Agilent).
Description of mRNA sequencing protocol
Sequencing was performed on GAII (Illumina). Cluster gener-
ation and sequencing was performed according to manufac-
turer’s instructions. Forty-ﬁve cycles of sequencing were
performed on n ¼ 8 samples (four individuals) using the
SBS sequencing kit v1 (Illumina) and cycle sequencing kit
v1/2. For the sequence capture sample (individual 5), 76 bp
sequencing reads using SBS sequencing kit v2 were performed.
All the sequencing data used in this study have been submitted
to the short read archive (accession number SRA008367).
ASE validation by C-BASE
cDNA used for ASE validation was synthesized from the frag-
mented total RNA using Superscript III RT kit (Invitrogen).
Forward and reverse PCR primers were designed against con-
served sequences near the SNPs rs2064068, rs10405893 and
rs1060819, in FAM118A, CALM3 and ATHL1, respectively,
to amplify a 200–230 bp product using AmpliTaq Gold
(Applied Biosystems, ABI, Warrington, UK). Primer
sequences are listed in Supplementary material, Table S2.
Both genomic DNA and cDNA, synthesized from fragmented
total RNA, of individuals that are heterozygous at the reporter
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agarose gel using a QIAquick gel extraction kit (QIAGEN).
Puriﬁed PCR product was ligated into pCR4-TOPO Vector
and transformed chemically into One Shot Top 10 competent
cells (Invitrogen). Transformed cells were spread onto
Luria-Broth agar plates containing Ampicillin and incubated
at 378C overnight. Colonies were picked from the agar
plates and directly inserted into plates with pre-aliquoted
PCR mastermix of AmpliTaq Gold and T3 (50-ATT
AACCCTCACTAAAGGGA-3) and T7 (50-TAATACGACT
CACTATAGGG-30) primers. Colonies were screened using
TaqMan genotyping assays designed by the assay-by-design
service from ABI. Alleles were scored on SDS v2.2.2 software
(ABI) manually and counted.
ASE validation by sequencing
Puriﬁed PCR products, as above, were sequenced using the
corresponding forward or reverse primer in duplicate reac-
tions. The sequencing reactions were performed using
Applied Biosystems’ BigDye (version 3.1) chemistry and
resolved using an ABI 3700 Genetic Analyzer. PeakPicker
software v2.0 was used to calculate normalized peak height
ratios as described in (18).
Read alignment
Our reference sequence set was designed for RNA-seq PE
mapping. We used the Ensembl database version 52 to
obtain, for each annotated gene, the transcript with the
largest number of exons and included this main spliced tran-
script in our reference set. Second, we added one sequence
per intron, extending intron boundaries 40 bp on each side to
allow mapping of reads overlapping exon–intron junctions,
but ensuring that 45 bp read would still map uniquely. In
addition, we included one sequence per non-standard exon–
exon junction (up to three skipped exons, i.e. junctions 1–3,
1–4, 1–5 but not 1–6). These junction sequences consist of
40 bp on each side of the exon–exon junction, such that a
45 bp read would have to overlap the junction by at least
5 bp. Last, a version of the reference DNA genome with
masked annotated transcripts was included. This reference
set was designed such that no region longer than 40 bp is rep-
resented twice, thus avoiding multiple mapping issues with
45 bp reads. However, the same SNP can be represented in
different sequences and our ﬁnal processing merged the data
when a single SNP mapped to multiple sequences (Perl tools
for reference building available at http://www.gene.cimr.cam.
ac.uk/todd/).
Reads were mapped using novoalign V2.05.12 PE mode for
paired reads, using the group mapping option for all the
sequences (main transcript, introns and non-standard exon–
exon junctions) originating from the same transcript (par-
ameters -v 20 20 200 [.]([^_] )_). PE mapping also used
adapter trimming (option -a). SE mode was used for SE data
(parameters -t 150). Quality reads were deﬁned as uniquely
mapped reads with phred-scaled probability score (30)  20
(i.e. maximum estimated mapping error rate of 1 per 100
reads). On average, 60% of the total number of sequenced
45 bp passed this quality read threshold. We wrote a tool,
novoPile (available at http://www.gene.cimr.cam.ac.uk/todd/)
to generate a ‘pileup’ ﬁle of bases mapping to individual refer-
ence sequence positions directly from the novoalign output.
We excluded from this ‘pileup’ reads with more than ﬁve
mismatches. We also ﬁltered out duplicate reads that were
identiﬁed in the PE data (option rmDup).
Identifying heterozygous dbSNPs and indels
To call SNPs heterozygous for ASE, we required that, follow-
ing the exclusion of low mapping score reads and low-quality
score calls, the read depth was  50 and the frequency of the
second most common SNP was at least 15%. Genes located in
the HLA region were excluded from this analysis because of
the elevated polymorphism level and potential biases this
polymorphism might introduce during the mapping process.
Indels were called using the output from novoalign. Only
indels supported by at least four independent reads were con-
sidered to be true calls.
Quality ﬁltering for heterozygous SNPs
We used two statistical tests to ﬁlter out unreliable heterozy-
gous SNPs. To verify that the allelic call is independent of
the position of the SNP within the 45 base reads, we compared
both distributions of positions using the Kolmogorov–
Smirnov test. SNPs with P-values more signiﬁcant than 0.01
were excluded. To check for strand-speciﬁc biases, we used
a goodness-of-ﬁt x
2 test on the 2 by 2 table of allelic calls
by strand. Again, SNPs with P-values more signiﬁcant than
0.01 were excluded. SNPs within 45 bases of a called indel
were also excluded from this analysis.
When restricting the analysis to HapMap SNPs, we used
HapMap SNPs in the CEPH population with minor allele fre-
quency .1% and call rate .95% (2239 392 SNPs total and
87796 of them were located in spliced transcripts).
Testing for allelic imbalance
Testing a single SNP for allelic imbalance uses a x
2
goodness-of-ﬁt test for even frequencies of both alleles.
When more than one heterozygous SNP are present in the
same transcript and the phase is known, the counts can be
summed across heterozygous SNPs, counting only once
reads overlapping multiple SNPs. This phasing information
can be obtained directly from the RNA-seq data, provided
that at least one read pair overlaps both heterozygous SNPs.
Tools for phasing data from short PE reads (novoPhase, avail-
able at http://www.gene.cimr.cam.ac.uk/todd/). Alternatively,
SNPs in high linkage disequilibrium can be phased in silico,
provided that this information is available.
Sequence capture and sequencing for individual 5
Sequence capture probes were designed by Nimblegen
(Madison, USA) to tile CCDS reference transcript for the fol-
lowing genes: BACH2, CAPZA1, CD69, CLEC16A, CTLA4,
DEXI, FAM118A (included as a positive control known
eQTL), ICOS, IFIH1, IL2, IL2RA, IL15RA, IL18RAP, IL21,
KIAA1109, LSP1, MAPKAPK2, PFKFB3, PRKCQ, PTPN2,
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designedtotiletheintronicregionswithineachtranscript,extend-
ing40 bpintotheexonsoneachsidetocaptureretainedintronic–
exonic spanning reads since poly(A)-selected RNA contains
preRNA. Oligonucleotide probes (between 60 and 100 bp)
were designed, excluding any sequences mapping to repeat
regions or that were not unique in the human genome permitting
80%ofthetotal1.7 Mbgenomicregionstobetiled.Probeswere
synthesized on 385000 feature glass slide arrays.
Standard Solexa library preps were conducted according to
the manufacturer’s instructions (Illumina). For the RNA
samples, a poly(A)-selected RNA-seq library was constructed
as described above. For the genomic DNA sample, DNA was
extracted from whole blood using the Gentra PUREGENE
DNA Extraction kit (QIAGEN) according to manufacturer’s
instructions. Five micrograms of DNA was fragmented by
sonication (Bioruptor, Diagenode, USA) before a standard
PE library was constructed. After a single gel-extraction step
to size select a 350 bp library, the adapter ligated library
was ampliﬁed with 12 cycles of PCR. One microgram of
either genomic DNA or RNA (cDNA) PE Genome Analyzer
library was added to 100 mg of Cot-1 DNA (Invitrogen)
with 1 ml each of the PE enhancing oligos (1 mM). The
libraries were then hybridized to the sequence capture array
for 72 h at 428C according to the manufacturer’s instructions.
Arrays were stringently washed at 47.58C, and hybridized
DNA eluted with NaOH. At multiple stages of the protocol,
DNA size ranges were checked by Agilent Bioanalyzer and
concentration by OD260/280 (Nanodrop). Hybridization and
elution of libraries was undertaken by Roche Nimblegen in
Madison, USA.
SUPPLEMENTARY MATERIAL
Supplementary material is available at HMG online.
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